The effects of original Russian 3-hydroxypyridine and succinic acid derivatives (emoxypine, Reamberin, and Mexidol) on monoamine oxidase (MAO-A and MAO-B) activity in rat liver were studied in vitro. The study drugs used in vitro at concentrations in the pharmacokinetic range (10 9 to 10 6 M), were found to have MAO-modulating actions, the directions depending on their chemical structural properties. The isolated 3-hydroxypyridine derivative emoxypine decreased MAO-A activity by 34 – 44% and MAO-B activity by 9 – 10% (p < 0.05 in both cases). The succinic acid derivative Reamberin increased MAO-A activity by 2-3% and MAO-B activity by 14% (p < 0.05 in both cases). Mexidol, which is a derivative of both 3-hydroxypyridine and succinic acid, decreased MAO-A activity by 13% and MAO-B activity by 4% (p < 0.05 in both cases). The 2-ethyl-3-methyl-3-hydroxypyridinium cation and the succinate anion were antagonists in terms of their MAO-modulating actions. Combining these antagonist ions into the structure of Mexidol led to complete loss of the MAO-stimulating effect of the succinate part and a significant reduction in the MAO-inhibiting action of the 3-hydroxypyridine component.
Similar content being viewed by others
References
V. Z. Gorkin, Amine Oxidases and their Importance in Medicine [in Russian], Meditsina, Moscow (1981), pp. 24 – 28.
V. Z. Gorkin and L. N. Ovchinnikova, Biomed. Khim., 39(4), 2 – 10 (1993).
D. E. Edmondson, Cur. Pharm. Design, 20(2), 155 – 160 (2014).
J. C. Shih, J. B. Wu, and K. Chen, J. Neural. Transm., 118(7), 979 – 986 (2011).
C. S. Wang, E. Billett, A. Borchert, H. Kuhn, et al., Cell. Mol. Life Sci., 70(4), 599 – 630 (2013).
M. S. Song, D. Matveychuk, E. M. MacKenzie, et al., Prog. Neuropsychopharmacol. Biol. Psychiatry, 44, 118 – 124 (2013).
S. K. Al-Nuaimi and E. M. MacKenzie, Am. J. Ther., 19(6), 436 – 448 (2012).
I. A. Volchegorskii, M. G. Moskvicheva, and E. N. Chashchina, Ter. Arkhiv, 77(10), 10 – 15 (2005).
I. A. Volchegorskii and K. M. Mester, Zh. Nevrol. Psikhiat. im. S. S. Korsakova, 3, 19 – 24 (2010).
V. P. Galenko-Yarosheskii, O. N. Gulevskaya, A. V. Zelenskaya, et al., Novye Tekhnol., 2, 166 – 171 (2011).
I. A. Volchegorskii, L. M. Rassokhina, I. Yu. Miroshnichenko, et al., Byull. Éksperim. Biol. Med., 150(9), 295 – 301 (2010).
I. A. Volchegorskii, I. I. Dolgushin, O. L. Kolesnikov, and V. E. Tseilikman, Experimental Modeling and Laboratory Evaluation of the Adaptive Reactions of the Body [in Russian], Chelyabinsk Sate Pedagogical University Press, Chelyabinsk (2000), pp. 52 – 59.
I. A. Volchegorskii, N. A. Skobeleva, and R. I. Lifshits, Vopr. Med. Khim., 37(1), 86 – 89 (1991).
K. F. Tipton, G. Davey, and M. Motherway, Curr. Protoc. Toxicol., Supplement. 30, UNIT 4.21, 4.21.1-4.21.42 (2006).
E. Siewens and A. D’Iorio, Canad. J. Biochem., 48(6), 659 – 663 (1970).
V. N. Orekhovich, Contemporary Methods in Biochemistry [in Russian], Meditsina, Moscow (1977), pp. 19 – 21.
I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, et al., Éksperim. Klin. Farmakol., 76(7), 6 – 10 (2013).
L. M. Rassokhina, Doctoral Dissertation in Medical Sciences [in Russian], Moscow (2015).
I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, Éksperim. Klin. Farmakol., 74(12), 27 – 32 (2011).
N. Singh, J. Hroudova, and Z. Fišar, Mol. Neurobiol., September, 1 – 11 (2016).
I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, et al., Éksperim. Klin. Farmakol., 77(5), 6 – 9 (2014).
I. A. Volchegorskii, E. V. Pravdin, and T. V. Uzlova, Éksperim. Klin. Farmakol, 75(11), 22 – 27 (2012).
I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, Probl. Éndokrinol., 2, 27 – 35 (2010).
D. E. Kemp, F. Ismail-Beigi, S. J. Ganocy, et al., J. Affect. Disord., 136(3), 1164 – 1173 (2012).
A. L. Markowska, M. Mooney, and W. E. Sonntag, Neuroscience, 87(3), 559 – 569 (1998).
N. Morin, V. Visentin, D. Calise, et al., J. Pharmacol. Experim. Ther., 303(3), 1238 – 1247 (2002).
S. V. Okovityi, S. V. Rad’ko, and E. B. Shustov, Khim.-Farm. Zh., 49(9), 3 – 7 (2015); Pharm. Chem. J., 49(9), 573 – 577 (2015).
V. P. Zherdev, A. K. Sariev, A. A. Dvoryaninov, et al., Byull. Éksperim. Biol. Med., 3, 325 – 327 (1986).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 52, No. 1, pp. 3 – 7, January, 2018.
Rights and permissions
About this article
Cite this article
Volchegorskii, I.A., Sinitskii, A.I., Miroshnichenko, I.Y. et al. Effects of 3-Hydroxypyridine and Succinic Acid Derivatives on Monoamine Oxidase Activity In Vitro. Pharm Chem J 52, 26–29 (2018). https://doi.org/10.1007/s11094-018-1760-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-018-1760-2